Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Colin Graney

Podiatrist, Foot & Ankle Surgery Madison, WI Doctor of Podiatric Medicine

NPI 1295279461 CMS profile 2774929

664 W. Washington Ave, Madison, WI 53703

Open in the dashboard

General payments

$14,751

92 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Colin Graney of Madison, WI is reported in the CMS Open Payments database as having received $14,751 across 92 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $253 7
2024 General $546 10
2023 General $2,461 18
2022 General $1,492 8
2021 General $3,361 11
2020 General $3,168 20
2019 General $3,470 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Colin Graney
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Colin Graney were reported at $253. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Colin Graney Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $3,470 $389 $118–$1,406 $163
2020 $3,168 $191 $62–$691 $114
2021 $3,361 $329 $104–$1,341 $132
2022 $1,492 $419 $125–$1,611 $149
2023 $2,461 $377 $128–$1,164 $160
2024 $546 $394 $134–$1,168 $164
2025 $253 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $7,980 31 payments
  2. Great Lakes Orthopedics $2,806 9 payments
  3. Vilex in Tennessee, Inc. $2,353 12 payments
  4. Organogenesis Inc. $614 14 payments
  5. Triad Life Sciences Inc. $191 1 payment
  6. EnduroMEd, LLC $177 3 payments
  7. Paragon 28, Inc. $150 1 payment
  8. MIMEDX Group, Inc. $108 4 payments
  9. Urgo Medical North America, LLC $82 3 payments
  10. Osteomed LLC $73 1 payment
  11. Other $217 13 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $6,879 6 payments
  2. Travel and Lodging $4,117 17 payments
  3. Food and Beverage $2,755 68 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,000 1 payment
Products named General payments · program years 2019–2025
  1. HINTERMANN $2,353 12 payments
  2. Puraply $440 12 payments
  3. INNOVAMATRIX AC $191 1 payment
  4. PHANTOM Hindfoot $150 1 payment
  5. NuShield $111 1 payment
  6. DISTAL EXTREMITIES IMPLANTS FOOT & ANKLE TTC NAIL $77 1 payment
  7. DISTAL EXTREMITIES IMPLANTS SOFT TISSUE IB LIGAMENT AUGMENTATION $74 1 payment
  8. EXT-ExtremiFix Midsize/Large $73 1 payment
  9. Apligraf $63 1 payment
  10. VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP $42 2 payments
  11. Other $438 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

186

Median for Podiatry: 160

Drug cost

$1,228

Median for Podiatry: $2,368

Branded share of claims

51.1%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ondansetron Odt Ondansetron Brand 45 $440
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 39 $372
Cephalexin Generic 60 $210
Meloxicam Generic 18 $78
Doxycycline Hyclate Generic 13 $71
Acetaminophen-Codeine Acetaminophen With Codeine Brand 11 $56

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$5,901

Medicare's payments for the services billed

Medicare patients

55

Average age 74

Services billed

135

28 women, 27 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 49%
Diabetes 42%
Heart failure 31%
Ischemic heart disease 27%
Chronic kidney disease 24%
Depression 24%
Cancer 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

92 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record